GoKawiil
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
31.
32.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
33.
34.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
36.
37.
De novo design of GPCR exoframe modulators
(feeds.nature.com)
38.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
39.
41.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
(futurism.com)
42.
Why Novo Nordisk stock fell 7% after a telehealth startup’s announcement
(feeds.feedburner.com)
43.
44.
Ozempic just released its own version of the iconic Mac vs. PC ad
(feeds.feedburner.com)
47.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)
48.
Wegovy pill: Where to find Novo Nordisk’s new GLP-1 medication—and how much it costs
(feeds.feedburner.com)
49.
Wegovy pill: Where to find Novo Nordisk’s new GLP-1 for weight loss—and how much it costs
(feeds.feedburner.com)
50.
FDA approves Novo Nordisk weight-loss pill. Here’s what to know
(feeds.feedburner.com)
51.
52.
FDA Approves Pill Version of Wegovy
(wired.com)
53.
Ozempic does not slow Alzheimer's, study finds
(news.ycombinator.com)
54.
Novo Nordisk stock slides as its Alzheimer’s drug trials fail
(feeds.feedburner.com)
55.
56.
Semantic design of functional de novo genes from a genomic language model
(feeds.nature.com)
57.
GLP-1 price war heats up as Novo Nordisk offers $199 starter doses
(feeds.feedburner.com)
58.
59.
Man Collapses During Oval Office Event on Drug Prices
(futurism.com)
60.
Atomically accurate de novo design of antibodies with RFdiffusion
(feeds.nature.com)